Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Developmental defect during embryogenesis
Toxic or drug-related embryofetopathy
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
-
Fetal alcohol syndrome 17 trials
-
Thalidomide embryopathy 1 trial
-
Fetal trimethadione syndrome 0 trials · 1 incl. sub-types Sub-types →
-
Acitretin/etretinate embryopathy 0 trials
-
Cocaine embryofetopathy 0 trials
-
Diethylstilbestrol syndrome 0 trials
-
Fetal carbamazepine syndrome 0 trials
-
Fetal hydantoin syndrome 0 trials
-
Fetal iodine syndrome 0 trials
-
Fetal methylmercury syndrome 0 trials
-
Fetal minoxidil syndrome 0 trials
-
Fetal phenothiazine syndrome 0 trials
-
Fetal valproate syndrome 0 trials
-
Indomethacin embryofetopathy 0 trials
-
Isotretinoin syndrome 0 trials
-
Methimazole embryofetopathy 0 trials
-
Mycophenolate mofetil embryopathy 0 trials
-
Phenobarbital embryopathy 0 trials
-
Propylthiouracil embryofetopathy 0 trials
-
Toluene embryopathy 0 trials
-
Vitamin K-antagonist embryofetopathy 0 trials